Moderna, the biotechnology company behind a key COVID-19 vaccine, says it will build a new facility in Africa, aimed at producing up to 500 million doses of vaccines a year.
Moderna, the biotechnology company behind a key COVID-19 vaccine, says it will build a new facility in Africa, aimed at producing up to 500 million doses of vaccines a year.